Tumor protein 63 (TP63) comprises multiple isoforms and plays an important role during embryonic development. It has been shown that TP63 knockdown inhibits myogenic differentiation, but which isoform is involved in the underlying myogenic regulation remains uncertain. Here, we found that two transcripts of TP63, namely, TAp63α and Np63α, are expressed in chicken skeletal muscle. These two transcripts have distinct expression patterns and opposite functions in skeletal muscle development. TAp63 has higher expression in skeletal muscle than in other tissues, and its expression is gradually upregulated during chicken primary myoblast differentiation. Np63 can be expressed in multiple tissues and exhibits stable expression during myoblast differentiation. TAp63α overexpression inhibits myoblast proliferation, induces cell cycle arrest, and enhances myoblast differentiation. However, although Np63α has no significant effect on cell proliferation, the overexpression of Np63α inhibits myoblast differentiation. Using isoform-specific overexpression assays following RNA-sequencing, we identified potential downstream genes of TAp63α and Np63α in myoblast. Bioinformatics analyses and experimental verification results showed that the differentially expressed genes (DEGs) between the TAp63α and control groups were enriched in the cell cycle pathway, whereas the DEGs between the Np63α and control groups were enriched in muscle system process, muscle contraction, and myopathy. These findings provide new insights into the function and expression of TP63 during skeletal muscle development, and indicate that one gene may play two opposite roles during a single cellular process.
Tumor protein 63 (TP63) comprises multiple isoforms and plays an important role during embryonic development. It has been shown that TP63 knockdown inhibits myogenic differentiation, but which isoform is involved in the underlying myogenic regulation remains uncertain. Here, we found that two transcripts of TP63, namely, TAp63α and Np63α, are expressed in chicken skeletal muscle. These two transcripts have distinct expression patterns and opposite functions in skeletal muscle development. TAp63 has higher expression in skeletal muscle than in other tissues, and its expression is gradually upregulated during chicken primary myoblast differentiation. Np63 can be expressed in multiple tissues and exhibits stable expression during myoblast differentiation. TAp63α overexpression inhibits myoblast proliferation, induces cell cycle arrest, and enhances myoblast differentiation. However, although Np63α has no significant effect on cell proliferation, the overexpression of Np63α inhibits myoblast differentiation. Using isoform-specific overexpression assays following RNA-sequencing, we identified potential downstream genes of TAp63α and Np63α in myoblast. Bioinformatics analyses and experimental verification results showed that the differentially expressed genes (DEGs) between the TAp63α and control groups were enriched in the cell cycle pathway, whereas the DEGs between the Np63α and control groups were enriched in muscle system process, muscle contraction, and myopathy. These findings provide new insights into the function and expression of TP63 during skeletal muscle development, and indicate that one gene may play two opposite roles during a single cellular process.
INTRODUCTION
Tumor protein 63 is a p53 family member required for limb, craniofacial and epithelial development (Yang et al., 1999) . Unlike for p53, several messenger RNAs are transcribed from the TP63 gene due to the use of two promoters and to alternative splicing (Lin et al., 2015) . These mRNAs encode at least six TP63 isoforms (Guo and Mills, 2007) . Isoforms with the N-terminal transactivation (TA) domain are referred to as the TA isoforms, and the N-terminal truncated ( N) isoform lacks the TA domain. It is well known that TP63 is involved in the formation of the epidermis. However, different TP63 isoforms perform different functions during epithelial development.
Np63 isoforms are important for maintaining the proliferative potential of the basal layer, whereas TAp63 isoforms contribute to late stage differentiation in mature keratinocytes (Candi et al., 2007) . Different TP63 isoforms probably regulate gene sets that have completely distinct biological functions (Wu et al., 2003) , and different isoforms may perform cell-type specific functions (Guo and Mills, 2007) . For example, TAp63α promotes proliferation in the mouse epidermis (Koster et al., 2006) , while it induces apoptosis in Hep3B cells (Gressner et al., 2005) . Np63 overexpression promotes HNSCC cell survival (Rocco et al., 2006) , while it induces apoptosis in the non-small cell lung carcinoma cell line H1299 (Lo et al., 2006) . Therefore, it is important to distinguish the different functions of TP63 isoforms during different cellular processes.
Skeletal muscle development is a complex process that is regulated at multiple levels. Many transcription factors and miRNAs are involved in the regulation of myogenesis (Braun and Gautel, 2011; Luo et al., 2013) . It has been shown that p53 family members play a role in controlling myogenic differentiation (Cam et al., 2006) . The p53 protein transactivates the RB gene, which plays a critical role in cell cycle exit in differentiated myocytes (Novitch et al., 1996) . p63 and p73 induce the transcription of p57, maintain RB protein activity, and facilitate myogenic differentiation (Cam et al., 2006) . However, the isoforms of TP63 have never been addressed in these studies. Which isoform is expressed during myogenic differentiation, and which isoform plays a major role in myogenic differentiation remain unclear. Recently, it was found that one of the TP63 isoforms, TAp63gamma, is involved in myogenic differentiation, and that the knockdown of TAp63 inhibited myotube formation (Cefalu et al., 2015) . However, there are no results describing the expression and function of any other TP63 isoforms. miR-203 is widely known as a skin-specific miRNA that plays an important role in epidermal development (Yi et al., 2008) . miR-203 can regulate epidermal stratification and differentiation by directly repressing the expression of TP63 (Lena et al., 2008) . However, in our previous work, we found that the "skin-specific miRNA" miR-203 could also be expressed in and function in the development of skeletal muscle (Luo et al., 2014) . During muscle differentiation, miR-203 inhibits myoblast proliferation and differentiation by repressing c-Jun and MEF2C, respectively. In addition to c-Jun and MEF2C, TP63 was also found to be a direct target gene of miR-203 in skeletal muscle. Considering that TP63 has diverse transcripts and plays roles in muscle development in mammals, here, we explored its transcription, expression, and functional significance in chicken myoblast proliferation and differentiation. These results were important for understanding the function and regulation of TP63 isoforms in myogenesis.
MATERIALS AND METHODS

Ethics Statement
This study was carried out in accordance with the principles of the Basel Declaration and recommendations of the Statute on the Administration of Laboratory Animal, the South China Agriculture University Institutional Animal Care and Use Committee. The protocol was approved by the South China Agriculture University Institutional Animal Care and Use Committee (approval ID: 2017046).
Animals
The embryonic and 7-week-old Xinghua female chickens were used in this study. For qPCR of TP63 in different tissues, the tissues were isolated from four 7-week-old Xinghua female chickens. For primary myoblast isolation, at least six embryos at embryo day 11 (E11) were used in each experiment. The sex of each embryos was determined by PCR with the sex-specific primers (Li et al., 2017) .
Cell Culture
Chicken embryo fibroblast cell line was cultured in high-glucose Dulbecco's modified Eagle's medium (Gibco) with 10% fetal bovine serum and 0.2% penicillin/streptomycin. The isolation and culture of chicken primary myoblasts were carried out as previously described (Li et al., 2017) .
RNA Extraction, cDNA Synthesis, and Quantitative Real-Time PCR Total RNA was extracted from tissues or cells using RNAiso reagent (Takara, Otsu, Japan). The reverse transcription reaction for mRNA was performed with PrimeScript RT reagent Kit with gDNA Eraser (Takara) according to manufacturer's manual. qPCR program was carried out in Bio-Rad CFX96 RealTime Detection System (Bio-Rad, Hercules, CA, United States) with iTaq TM Universal SYBR R Green Supermix (Bio-Rad). All reactions were run in triplicate. The 2 − C t method was used to measure gene expression with β-actin as the reference gene (Kenneth and Thomas, 2001 ).
The 5 and 3 Rapid Amplification of cDNA Ends (RACE)
For 5 RACE and 3 RACE, total RNA isolated from chicken skeletal muscle and pooled total RNAs from different tissues were used. The detailed procedure was carried out according to previously described (Luo et al., 2015) . All of the primers used in RACE were summarized in Supplementary Table S1 .
RNA Sequencing
The chicken primary myoblasts transfected with TAp63α, Np63α, or GFP control overexpression vectors were harvested and total RNA was extracted using RNAiso reagent (Takara). Then the RNA samples were sent to Beijing Genomics Institute for RNA sequencing by using BGISEQ-500 (BGI, Wuhan, China). All the sequence data have been deposited in NCBI's Gene Expression Omnibus (GEO 1 ) and are accessible through GEO series accession number GSE114452.
Luciferase Reporter Assays
Based on the TP63 mRNA sequence we obtained, primers for amplifying the TP63 3 UTR region with predicted gga-miR-203 binding site were designed (Supplementary Table S1 ). The plasmid pmirGLO-TP63-3 UTR (wild-type) and pmirGLO-TP63-3 UTR-mutant (mutant with gga-miR-203 potential binding site deleted) were prepared for verification of target relationship between gga-miR-203 and TP63 mRNA. gga-miR-203 mimic (50 nM, RiboBio, Guangzhou, China) and pmirGLO-TP63-3 UTR (200 ng) were co-transfected into DF-1 cells (3 × 10 4 cells) by using Lipofectamine 3000 reagent (Invitrogen) according to the manufacturer's instructions. After 48 h, Luc-pair Duo-Luciferase Assay Kit 2.0 (GeneCopoeia, Rockville, MD, United States) was used to analyze the activities of luciferases. The luminescent signal was quantified using Synergy 2 Multi-mode Microplate Reader (Biotek, Winooski, VT, United States) and analyzed with Gene5 software (Biotek).
Plasmid Construction
The TP63 overexpression vectors were constructed according to the user manual of Easy Ligation Kit (Sidansai, Shanghai, China). TAp63α and Np63α coding sequences were amplified from chicken leg muscle cDNA by PCR. The PCR products were cloned into the pSDS-204 vector (Sidansai). The successful TAp63α and Np63α overexpression vectors were confirmed by agarose gel electrophoresis and DNA sequencing.
Immunoblotting and Immunofluorescence
Immunoblotting and immunofluorescence were performed as previously described (Luo et al., 2016) . The following antibodies were used for immunoblotting: anti-MYOG (Biorbyt, Cambridge, United Kingdom), anti-MYOD (BD Biosciences, San Jose, CA, United States), anti-MyHC (Developmental Studies Hybridoma Bank, Iowa City, IA, United States) and anti-Tubulin (Bioworld, Minneapolis, MN, United States). The protein expression were presented as the ratio between indicated protein gray value and Tubulin gray value. We set the mean expression value of pSDS204-GFP group or si-NC group to 1, and the other group was a fold change comparing to the control group. Results are mean ± SEM from three independent experiments. The following antibody and reagent were used for immunofluorescence: anti-MyHC (DSHB), FITC-conjugated anti-mouse IgG (EarthOx, Millbrae, CA, United States), 4 6-diamidino-2-phenylindole (DAPI, Beyotime, Jiangsu, China).
Cell Cycle Analysis
After 48 h transfection of gene overexpression vectors, chicken primary myoblasts were collected and fixed in 75% ethanol overnight at −20 • C. After ethanol fixation, the cells were stained with 50 µg/mL propidium iodide (Sigma) containing 1 http://www.ncbi.nlm.nih.gov/geo 10 µg/mL RNase A (Takara) and 0.2% (v/v) Triton X-100 (Sigma) for 30 min at 4 • C. BD Accuri C6 flow cytometer (BD Biosciences) was subsequently used to analyze the cell cycle with Cell Cycle Analysis Kit (Thermo Fisher Scientific, Waltham, MA, United States), and the data analysis was performed using FlowJo 7.6 software (Verity Software House).
CCK-8 Assay
Primary myoblast were cultured in 96-well plates. A total of 10 µL of Cell counting kit-8 reagent (Dojindo, Kumamoto, Japan) was added into each well and incubated for 1 h. The assay was repeated at different time points of 12, 24, 36, 48 h after transfection. The absorbance was measured at 450 nm by a Model 680 Microplate Reader (Bio-Rad). All the data were acquired by averaging the results from six independent experiments.
RNA Oligonucleotides
Isoform-specific siRNAs against chicken TAp63α and Np63α were all purchased from RiboBio (RiboBio, China). Target sequence of si-TAp63α is 5 -GGGACTTCC TGGAACAGCCAATATG-3 . Target sequence of si-Np63α is 5 -CCGAGTCCTGTTATCTTCCAAGTAG-3 .
Statistical Analysis
All data shown are mean ± SEM with at least three samples or cultures per group and three wells per culture. Well was considered the experimental unit for cell culture applications. We performed statistical analysis by using independent sample t-test through SPSS. We considered p < 0.05 to be statistically significant. * p < 0.05; * * p < 0.01.
RESULTS
TP63 Is a gga-miR-203 Target Gene and Is Involved in Myogenic Differentiation
In our previous study (Luo et al., 2014) , we found that the expression of TP63 was significantly downregulated when we transfected a gga-miR-203 mimic into chicken primary myoblasts. TargetScan (release 5.2) online software predicted that the TP63 mRNA is a direct target of gga-miR-203 ( Figure 1A) , and the predicted target site of gga-miR-203 in the 3 UTR of TP63 mRNA is highly conserved among vertebrates ( Figure 1B) . The dual-luciferase reporter gene assay confirmed that gga-miR-203 can directly bind to the predicted target site of gga-miR-203 in the 3 UTR of TP63 mRNA ( Figure 1C) . Considering that gga-miR-203 is a negative regulator of myogenic differentiation and that TP63 has been reported to play roles in myogenic differentiation, we next studied the roles of TP63 in chicken skeletal muscle differentiation. We synthesized a TP63 specific siRNA and found that this siRNA can efficiently inhibit TP63 expression ( Figure 1D) . Notably, TP63 knockdown significantly reduced the expression of MyHC (Figure 1E ), which is a terminal myogenic differentiation marker gene. Therefore, these results suggested that TP63 is a gga-miR-203 target gene and is involved in myogenic differentiation.
TAp63α and Np63α Are Two Conserved Transcripts Expressed in Chicken Tissues
It is well-known that that TP63 gene has multiple transcripts in mammals. However, only one transcript has been identified in chickens; this transcript is short, without a 5 UTR or 3 UTR (NM_204351.1 and AB045224.1). To study the TP63 transcripts in chickens, we collected total mRNA from chicken embryonic skeletal muscle and pooled tissues, respectively. By using 5 rapid-amplification of cDNA ends (RACE) and 3 RACE, we found two TP63 transcripts existing in chicken tissues (accession number MH238465 and MH238464 in the NCBI database). One of the transcripts which we obtained from skeletal muscle mRNA, has a gene structure similar to that of the TP63 transcript in NCBI (NM_204351.1), but our transcript contained a 178 bp 5 UTR and a 2,721 bp 3 UTR sequence (Figure 2A) . The other transcript was obtained from pooled tissues mRNA (Figure 2A ). This transcript also had a 2,721 bp 3 UTR but the transcription start site was different from that of the first transcript (Figure 2A) . By using ORFfinder, we obtained several potential ORFs in these two transcript (Supplementary Figure  S1) . The two longest ORFs among the predicted ORFs were then marked and subjected to BLAST analysis to find conserved proteins in the reference proteins database. The BLAST results showed that the ORF predicted from one of the chicken TP63 transcripts is conserved with TP63 isoform a (also known as TAp63α) in mice, whereas the other chicken TP63 transcript is conserved with TP63 isoform d (also known as Np63α) in mice (Supplementary Figure S2) . The BLAST search also showed that the chicken TAp63α and Np63α have high percent identities to the homologous proteins in quail, ducks, humans, mice, rats, pigs, and cattle (Figures 2B,C) . Amino acid alignment of the TAp63α and Np63α proteins showed that these two proteins were strongly conserved among mammals and birds (Figures 2D,E) . (E) Amino acid alignment of Np63α proteins from chickens, quails, ducks, humans, mice, rats, and pigs. Conserved sequences are marked with asterisks within the Clustal Co sequences. The data are the mean ± SEM of three cultures per group, and three wells per culture were assayed (n = 9/treatment group). An independent samples t-test was used to analyze the statistical differences between groups. * p < 0.05; * * p < 0.01. Therefore, these results suggested that TAp63α and Np63α are two conserved transcripts expressed in chicken tissues.
TAp63α and Np63α Play Opposite Roles in Chicken Myogenic Differentiation
Next, we studied the expression of TAp63α and Np63α in chicken tissues. Using TA-and N-specific primers and a realtime polymerase chain reaction (qPCR) assay, we found that TAp63 has higher expression in skeletal muscle than in other tissues ( Figure 3A) , whereas Np63 has high expression in bursal and thymus tissue and in skeletal muscle ( Figure 3B) . During myogenic differentiation, the expression of TAp63 was gradually upregulated, whereas the expression of Np63 was relatively stable ( Figure 3C) . As Figures 1D,E show, our siRNA designed for TP63 was not isoform-specific (Supplementary Figure S3) . To further study the functions of TAp63α and Np63α in chickens, we constructed TAp63α and Np63α overexpression vectors. Transfecting one of the TP63 overexpression vectors would upregulate the expression of that transcript without affecting the expression of the other transcript ( Figure 3D) . We then transfected these two vectors into chicken primary myoblasts, and induced the cells to differentiate. After 48 h, we found that TAp63α overexpression upregulated the mRNA and protein expression of MyHC (Figures 3E-G) , which is a terminal marker of myogenic differentiation. However, Np63α overexpression repressed MyHC expression (Figures 3E-G) . Additionally, MyHC immunofluorescence showed that TAp63α and Np63α have opposite effects on myotube formation (Figure 3H) , as indicated by the quantification of myotube areas ( Figure 3I) . On the other hand, we used isoformspecific siRNAs to knockdown the expression of TAp63α and Np63α ( Figure 3J ). TAp63α knockdown downregulated MyHC mRNA and protein expression, whereas Np63α knockdown upregulated MyHC mRNA and protein expression (Figures 3K-M) . Altogether, these results indicated that TAp63α and Np63α play opposite roles in chicken myogenic differentiation.
TAp63α and Np63α Regulate Different Sets of Genes in Myoblasts
To study the downstream genes of TAp63α and Np63α in chicken myoblast, we overexpressed these two transcripts in chicken primary myoblasts and collected the mRNA for RNA sequencing (RNA-seq). The RNA-seq results showed the successful overexpression of TAp63α and Np63α in myoblasts Relative protein expression after the transfection of si-TAp63α, si-Np63α, or si-NC. The data are the mean ± SEM of three cultures per group, and three wells per culture were assayed (n = 9/treatment group). An independent samples t-test was used to analyze the statistical differences between groups. * p < 0.05; * * p < 0.01. Myoblasts were transfected with pSDS204-TAp63α, pSDS204-Np63α, or pSDS204-GFP, followed by 48 h culture, and the cell cycle phase was then analyzed. (C) CCK-8 assay was performed to access the effects of TAp63α and Np63α overexpression on myoblast proliferation. (D) qPCR validation of the DEGs enriched in cell cycle pathway. (E) The heat-map of genes related to muscle system process, muscle contraction, and myopathy. (F) qPCR validation of the DEGs related to muscle system process, muscle contraction, and myopathy. The data are the mean ± SEM of three cultures per group, and three wells per culture were assayed (n = 9/treatment group). An independent samples t-test was used to analyze the statistical differences between groups. * p < 0.05; * * p < 0.01. (Figure 4A ), and numerous differentially expressed genes (DEGs) between the groups ( Figure 4B and Supplementary  Table S2) . From the gene expression heatmap we can see that the DEGs induced by TAp63α and Np63α are very different ( Figure 4B ). TAp63α overexpression resulted in 1616 significantly DEGs, whereas Np63α overexpression resulted in only 340 significantly DEGs ( Figure 4C) ; furthermore, there were only 143 overlapping DEGs between these two groups ( Figure 4C) . GO analysis revealed that the TAp63α-induced DEGs are enriched in the cell cycle, DNA replication, and nucleotide binding terms (Figure 4D) , whereas Np63α-induced DEGs are enriched in the developmental process, regulation of biological process, and protein binding terms ( Figure 4D ). In addition, KEGG pathway analysis revealed that TAp63α-induced DEGs are enriched in the cell cycle pathway, whereas Np63α-induced DEGs are enriched in the muscle development-or myopathy-related pathways ( Figure 4E) . Therefore, these results indicated that TAp63α and Np63α regulate different set of genes in myoblasts.
Identification of Major Downstream Regulatory Pathways and Functional Gene Groups of TAp63α and Np63α in Myoblast
From the GO and KEGG pathway analysis results, we can see that the cell cycle is a potential target pathway of TAp63α. Many genes involved in the cell cycle pathway were differentially expressed in TAp63α-overexpressing myoblasts compared to control myoblasts ( Figure 5A) . Notably, TAp63α overexpression increased the number of cells in the G0/G1 stage and decreased the number of cells in the S stage ( Figure 5B) , whereas Np63α overexpression decreased the number of cells in the G0/G1 stage ( Figure 5B) . The CCK-8 assay showed that TAp63α overexpression inhibited cell proliferation, whereas Np63α overexpression had no significant effect on this process ( Figure 5C ). The qPCR results verified that the expression of many DEGs in the cell cycle pathway was significantly inhibited in TAp63α-overexpressing myoblasts but not in Np63α-overexpressing cells (Figure 5D ).
From the GO and KEGG pathway analysis results, we found that many of the Np63α downstream genes were involved in the muscle system process, muscle contraction, and myopathy ( Figure 5E ). Our qPCR results validated that Np63α can regulate the expression of these genes ( Figure 5F ). Therefore, these results suggested that the cell cycle is a potential regulatory pathway targeted by TAp63α in myoblasts and that genes involved in muscle system process, muscle contraction, and myopathy were potential downstream targets of Np63α in myoblasts.
DISCUSSION
In this study, we cloned the full-length cDNA of the chicken Np63α, and found the full-length TAp63α transcript, which has never been reported in chickens. TAp63α and Np63α have different expression patterns and perform different functions during myoblast differentiation. TAp63α inhibits myoblast proliferation and promotes myoblast differentiation by regulating cell cycle-related genes, whereas Np63α inhibits myoblast differentiation by regulating genes related to muscle contraction, muscle system process, and myopathy (Figure 6) .
The TP63 gene has at least ten transcripts in humans, such as TAp63α, TAp63β, TAp63γ, TAp63δ, TAp63ε, Np63α, Np63β, Np63γ, Np63δ, and Np63ε (Mangiulli et al., 2009) . TA and N represent 5 variants, and α, β, γ, δ, and ε represent 3 variants. However, we found only TAp63α and Np63α in chicken tissues. The 5 RACE result identified the TA and N transcripts, whereas 3 RACE identified only the α transcript. The other TP63 transcripts may also exist in chickens, but these transcripts may be expressed in different tissues with different time-course expression profiles. Because it is hard to design primers that can identify every single transcript, we used TA-and N-specific primers to detect TAp63 and Np63 in chicken tissues. Notably, TAp63 is mainly expressed in skeletal muscle, whereas Np63 can be expressed in multiple tissues. The upregulation of TAp63 and the stable expression of Np63 during chicken myoblast differentiation were consistent with the results in C2C7 (Cefalu et al., 2015) . However, the isoformspecific expression of the TP63 transcripts during myoblast differentiation needs further investigation.
The TP63 transcripts encode the corresponding isoforms and play different roles in cellular processes. We found that TAp63α and Np63α are not only differentially expressed but also play opposite roles in myogenic differentiation. Similarly, protein kinase C isoforms can play opposite roles in the proliferation, differentiation, and apoptosis of human HaCaT keratinocytes (Papp et al., 2004) , and p38 isoforms exert opposite effects on MKK6-mediated VDR transactivation (Pramanik et al., 2003) . These phenomena indicate that one gene can perform at least two different functions by expressing different isoforms during a single cellular process. However, the expression of these isoforms would be strictly controlled by gene expression regulation programs, such as alternative promoters, alternative splicing, and post-translational processing, so that the appropriate functional isoform is expressed at the appropriate time. In addition to playing opposite roles during a single cellular process, one TP63 isoform may influence the function of another during myogenic differentiation. For example, the upregulation of Np63α inhibited myoblast differentiation, which was induced by TAp63α. A previous study showed that Np63 can directly compete for TAp63 target promoters or sequester TAp63 to form inactive tetramers (Candi et al., 2007) . Therefore, it is possible that the two isoforms compete for a sub-set of target genes during myogenic differentiation. In this case, identifying the target genes of these two isoforms is important in order to reveal the mechanism of action of TAp63α and Np63α, as well as to confirm the interaction between these two isoforms.
TP63 is a well-known tumor suppressor gene that can regulate cell cycle progress and inhibit cancer cell proliferation (Benard et al., 2003) . Here, we found that the TAp63α isoform is capable of inducing cell cycle arrest in myoblasts and is able to inhibit myoblast proliferation. Cell cycle arrest is important for myogenic differentiation. Myoblasts permanently exit from the cell cycle during terminal differentiation (Derer et al., 2002) . The upregulation of TAp63α during myoblast differentiation may promote cell cycle arrest, therefore, facilitating the terminal differentiation of myoblasts. In addition, TP63 has been reported to play roles in the late stage of myogenic differentiation (Cefalu et al., 2015) . The knockdown of TAp63gamma would affect the expression of genes related to myogenesis and skeletal muscle contractility (Cefalu et al., 2015) . Our results also showed that TP63 isoforms could regulate myogenesis and muscle contraction and that the expression of many myogenic differentiation genes, such as MYH9, MYH10, RUNX1, ROCK1, ROCK5, MSTN, SMAD5, and CDKN1A, were significantly changed ( Supplementary Table S2 ). Therefore, the TP63 gene is involved in skeletal muscle cell proliferation and differentiation.
TP63 is a conserved transcription factor with multiple binding sites in the genome (McDade et al., 2014) . TP63 regulates the expression of downstream genes by through directly affecting the transcription of genes to whose promoter it binds (McDade et al., 2012) . A better way to identify downstream genes of TP63 is via chromatin immunoprecipitation (ChIP)-related assays, such as ChIP-chip or ChIP-sequencing. However, there is no isoformspecific ChIP-grade antibody for TP63 in chickens. Furthermore, studies investigating the genome-wide binding of TP63 did not use isoform-specific antibodies (McDade et al., 2012 (McDade et al., , 2014 . Not only will structural variations of protein isoforms affect protein function in cellular processes, but the binding sites will also be different (Kiselev et al., 2012) . Therefore, it is important to develop isoform-specific antibodies for TP63 to better understand its genome-wide regulation in specific cell types. In this study, we used isoform-specific overexpression assays and identified a list of TAp63α-and Np63α-specific potential downstream genes in myoblasts. Previous studies on TP63 in myogenesis used an siRNA strategy for functional investigation (Cam et al., 2006; Cefalu et al., 2015) . The siRNAs designed to knockdown TP63 expression were not isoformspecific (Cam et al., 2006; Cefalu et al., 2015) ; therefore, it is hard to demonstrate the specific function of each TP63 isoforms in myogenesis. Here, we used an isoform-specific overexpression assay to investigate the function of TAp63α and Np63α in myoblast proliferation and differentiation. Although this strategy is not optimal for screening the downstream target genes of TAp63α and Np63α, our results identified the specific functions of these two isoforms in myoblast differentiation. In conclusion, TP63 is important for skeletal muscle development, and the isoforms of TP63, namely, TAp63α and Np63α, play opposite roles in myoblast differentiation. 
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